Retatrutide tops semaglutide on A1C and weight loss in phase 3 TRANSCEND-T2D-2
Lilly says both retatrutide doses cut HbA1c by 2.2% versus 1.8% for semaglutide 2mg at week 80, with more than double the weight loss, across 1,298 adults.
Recap by typeshit. Full story at MPR.